Brief: Immuneering Corporation Q4 net income USD -15.1 million
01/03/2024 13:04
Mar 1 (Reuters) - Immuneering Corporation Q4 net income USD -15.1 million. * Q4 EPS USD -0.52
Recent news on Immuneering
See all newsImmuneering expects cash runway to fund operations into 2029
Immuneering posts smaller-than-expected Q1 net loss on lower R&D spend
U.S. STOCKS ON THE MOVE-GoPro, Prudential Financial, Whitestone REIT
U.S. STOCKS ON THE MOVE-US airlines, BlackRock, copper miners
U.S. STOCKS ON THE MOVE-Gap, Caterpillar, Solid Biosciences